A novel estrogen eceptor intramolecular folding-based titratable transgene expression system

Molecular Therapy

Volumn 17, Issue 10, 2009, Pages 1703-1711

  Paulmurugan, Ramasamy ^a   Padmanabhan, Parasuraman ^a   Ahn, Byeong Cheol ^a,b   Ray, Sunetra ^a   Willmann, Juergen K ^a   Massoud, Tarik F ^a,c   Biswal, Sandip ^a   Gambhir, Sanjiv S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kyungpook National University School of Medicine   (South Korea)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GLYCINE; PROTEIN P53; PROTEIN VP16; RALOXIFENE; THREONINE; TRANSCRIPTION FACTOR GAL4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GENE THERAPY; CELL STRAIN HEPG2; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIGAND BINDING; MOUSE; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN FOLDING; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSGENE; TUMOR XENOGRAFT; VALIDATION PROCESS; ANIMAL; CELL LINE; CHEMISTRY; GENE VECTOR; GENETICS; PROTEIN BINDING; TUMOR CELL LINE;

ANIMALIA; MUS;

ANIMALS; CELL LINE; CELL LINE, TUMOR; FEMALE; GENETIC VECTORS; HUMANS; MICE; PROTEIN BINDING; PROTEIN FOLDING; RECEPTORS, ESTROGEN; TRANSCRIPTIONAL ACTIVATION; TRANSGENES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349857675     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2009.171     Document Type: Article

References (28)

1. Vilaboa, N and Voellmy, R (2006). Regulatable gene expression systems for gene therapy. Curr Gene Ther 6: 421-438.
2. Goverdhana, S, Puntel, M, Xiong, W, Zirger, JM, Barcia, C, Curtin, JF et al. (2005). Regulatable gene expression systems for gene therapy applications: Progress and future challenges. Mol Ther 12: 189-211.
3. Zhao, HF, Boyd, J, Jolicoeur, N and Shen, SH (2003). A coumermycin/ novobiocin-regulated gene expression system. Hum Gene Ther 14 1619-1629.
4. Rubenstrunk, A, Orsini, C, Mahfoudi, A and Scherman, D (2003). Transcriptional activation of the metallothionein I gene by electric pulses in vivo: Basis for the development of a new gene switch system. J Gene Med 5: 773-783.
5. Mayo, KE, Warren, R and Palmiter, RD (1982). The mouse metallothionein-I gene is transcriptionally regulated by cadmium following transfection into human or mouse cells. Cell 29: 99-108.
6. Bienz, M and Pelham, HR (1986). Heat shock regulatory elements function as an inducible enhancer in the Xenopus hsp70 gene and when linked to a heterologous promoter. Cell 45: 753-760.
7. Shimizu-Sato, S, Huq, E, Tepperman, JM and Quail, PH (2002). A light-switchable gene promoter system. Nat Biotechnol 20: 1041-1044.
8. Baron, U, Freundlieb, S, Gossen, M and Bujard, H (1995). Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23: 3605-3606.
9. Miller, N and Whelan, J (1997). Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Hum Gene Ther 8 803-815.
10. Sirin, O and Park, F (2003). Regulating gene expression using self-inactivating lentiviral vectors containing the mifepristone-inducible system. Gene 323: 67-77.
11. Galimi, F, Saez, E, Gall, J, Hoong, N, Cho, G, Evans, RM et al. (2005). Development of ecdysone-regulated lentiviral vectors. Mol Ther 11: 142-148.
12. Lee, HS, Aumais, J and White, JH (1996). Hormone-dependent transactivation by estrogen receptor chimeras that do not interact with hsp90. Evidence for transcriptional repressors. J Biol Chem 271 25727-25730.
13. Kemp, R, Ireland, H, Clayton, E, Houghton, C, Howard, L and Winton, DJ (2004). Elimination of background recombination: Somatic induction of Cre by combined transcriptional regulation and hormone binding affinity. Nucleic Acids Res 32: E92.
14. Stebbins, MJ, Urlinger, S, Byrne, G, Bello, B, Hillen, W and Yin, JC (2001). Tetracycline-inducible systems for Drosophila. Proc Natl Acad Sci U S A 98: 10775-10780.
15. Legler, J, van den Brink, CE, Brouwer, A, Murk, AJ, van der Saag, PT, Vethaak, AD et al. (1999). Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line. Toxicol Sci 48: 55-66.
16. Brzozowski, AM, Pike, AC, Dauter, Z, Hubbard, RE, Bonn, T, Engström, O et al. (1997). Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389: 753-758.
17. Logie, C, Nichols, M, Myles, K, Funder, JW and Stewart, AF (1998). Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteins. Mol Endocrinol 12: 1120-1132.
18. Pike, AC, Brzozowski, AM, Walton, J, Hubbard, RE, Bonn, T, Gustafsson, JA et al. (2000). Structural aspects of agonism and antagonism in the oestrogen receptor. Biochem Soc Trans 28: 396-400.
19. Shiau, AK, Barstad, D, Loria, PM, Cheng, L, Kushner, PJ, Agard, DA et al. (1998). The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927-937.
20. Paulmurugan, R and Gambhir, SS (2006). An intramolecular folding sensor for imaging estrogen receptor-ligand interactions. Proc Natl Acad Sci U S A 103: 15883-15888.
21. Ray, S, Paulmurugan, R, Hildebrandt, I, Iyer, M, Wu, L, Carey, M et al. (2004). Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression. Hum Gene Ther 15: 681-690.
22. Gossen, M and Bujard, H (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547-5551.
23. Di Croce, L, Okret, S, Kersten, S, Gustafsson, JA, Parker, M, Wahli, W et al. (1999). Steroid and nuclear receptors. Villefranche-sur-Mer, France, May 25-27, 1999. EMBO J 18: 6201-6210.
24. Barnes, PJ (1996). Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol 97 (1 Pt 2): 159-168.
25. van der Saag, PT, Caldenhoven, E and van de Stolpe, A (1996). Molecular mechanisms of steroid action: A novel type of cross-talk between glucocorticoids and NF-kappa B transcription factors. Eur Respir J Suppl 22: 146s-153s.
26. Burcin, MM, O'Malley, BW and Tsai, SY (1998). A regulatory system for target gene expression. Front Biosci 3: C1-7.
27. Ngan, ES, Schillinger, K, DeMayo, F and Tsai, SY (2002). The mifepristone-inducible gene regulatory system in mouse models of disease and gene therapy. Semin Cell Dev Biol 13: 143-149.
28. Iyer, M, Wu, L, Carey, M, Wang, Y, Smallwood, A and Gambhir, SS (2001). Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci U S A 98: 14595-14600.